Nucleoside analogues in the treatment of chronic hepatitis B.
- 1 May 2000
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 15 (5) , E53-E60
- https://doi.org/10.1046/j.1440-1746.2000.02103.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- C ASE R EPORT: Dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis BJournal of Gastroenterology and Hepatology, 1999
- Lamivudine and intron a combination treatment in patients with chronic hepatitis B infectionJournal of Hepatology, 1998
- Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.Journal of Clinical Investigation, 1998
- The polarized hepatic human/rat hybrid WIF 12-1 and WIF-B cells communicate efficiently in vitro via connexin 32-constituted gap junctionsHepatology, 1998
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Ganciclovir treatment of hepatitis B virus infection in liver transplant recipientsHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Spread of hepatitis B virus (HBV) infection in the family members of blood donors with HBV serological markersJournal of Hepatology, 1991
- Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.Gut, 1985